Conference Call with Amara Raja Energy & Mobility Management and Analysts on Q4FY25 & Full year Performance and Outlook. Listen to the full earnings transcript.
Conference Call with Fairchem Organics Management and Analysts on Q4FY25 & Full Year Performance and Outlook. Listen to the full earnings transcript.
Conference Call with Ipca Laboratories Management and Analysts on Q4FY25 & Full Year Performance and Outlook. Listen to the full earnings transcript.
Finance company Abans Financial Services announced Q4FY25 & FY25 results Q4FY25 Financial Highlights: Total income stood at Rs 1064 crore for Q4FY25 compared to Rs 252 crore for Q4FY24 PAT stood at Rs 29.9 crore for Q4FY25 compared to Rs 21 crore for Q4FY24 FY25 Financial Highlights: Total income stood at Rs 3,283 crore for FY25 compared to Rs 1,380 crore for FY24 PAT stood at Rs 108 crore for FY25 compared to Rs 89 crore for FY24 With total Assets Under Management at Rs 3,210 crore, AFSL is reinforcing its stature as a rising global asset manager. The flagship Global Arbitrage Fund (GAF) has become a cornerstone of this growth, now managing over Rs 831 crore. Nirbhay Vassa, Executive Director & Group CFO. said “This upward trend in fee income reflects our intent to build a business that is not just growing—but growing right,” “As the mix of revenue shifts toward more annuity-led income, the quality of earnings improves, making us more predictable, scalable, and globally relevant.” Quote from Abhishek Bansal (Promoter and Chairman) “At Abans, we’ve always believed that in the world of finance, trust is the only lasting currency. Everything else—capital, risk, opportunity—flows around it. FY25 has reaffirmed this belief. As we scaled up operations, attracted new capital, and grew our global investor base, what stood out most was the trust placed in us—by partners, clients, and teams across geographies. This was a year of transformation. We crossed Rs 3,200 crore in assets under management, witnessed a structural shift in our earnings mix—with nearly 70% of our EBIT now driven by fee-based income, and mobilized over Rs 1,000 crore through our distribution networks. These are not just numbers—they represent a business model that is becoming more stable, predictable, and globally respected. But what gives me greater confidence is how we’ve achieved this growth—without over-leveraging, without compromising our risk framework, and without deviating from our long-term strategy. We have stayed true to our core: building a financial services platform that is capital-light, globally scalable, and rooted in governance. FY25 was about proving the strength of our foundation. FY26 will be about building on it—with conviction, with discipline, and most importantly, with trust at the centre of everything we do.” Result PDF
Electrical Equipment & Products company Ram Ratna Wires announced Q4FY25 & FY25 results Q4FY25 Financial Highlights: Revenue from Operations rose by 19.1%, from Rs 803.4 crore to Rs 956.7 crore. EBITDA increased by 23.3%, from Rs 36.8 crore to Rs 45.3 crore. EBITDA Margin improved slightly from 4.6% to 4.7%. PBT grew by 26.6%, from Rs 23.4 crore to Rs 29.6 crore. PAT declined by -3.8%, from Rs 19.4 crore to Rs 18.7 crore. FY25 Financial Highlights: Revenue from Operations increased by 23.2%, from Rs 2,983.2 crore to Rs 3,676.7 crore. EBITDA rose by 31.4%, from Rs 119.0 crore to Rs 156.3 crore. EBITDA Margin improved from 4.0% to 4.3%. PBT surged by 30.2%, from Rs 74.6 crore to Rs 97.2 crore. PAT grew by 28.5%, from Rs 54.6 crore to Rs 70.2 crore. Commenting on the Results, Shri Mahendrakumar Kabra, MD said, - "I’m pleased to share that FY25 closed on a strong note, with Q4 performance reinforcing our growth momentum. Revenue from Operations rose 19.1% year-on-year, supported by a 23.3% increase in EBITDA and a 26.6% rise in Profit Before Tax. The modest decline in PAT was due to accounting adjustment for higher tax expenses, and not reflective of our operational efficiency. This growth was led by resilient demand in our enameled wires and strips business, along with strong traction in copper tubes. We continue to diversify our portfolio, with the upcoming commissioning of the Bhiwadi copper tube facility and our recent entry into BLDC motors, which are expected to contribute meaningfully going ahead. We are also actively exploring opportunities in the copper foils segment to further strengthen our future pipeline. The Board approved increase in our stake in Tefabo Product Pvt. Ltd. adds further momentum. With a clear strategic roadmap and focused execution, we are wellpositioned to sustain our growth in FY26 and beyond. Thank you for your continued support.” Result PDF
Conference Call with Concord Biotech Management and Analysts on Q4FY25 & Full Year Performance and Outlook. Listen to the full earnings transcript.